Srinath Sanda
Overview
Explore the profile of Srinath Sanda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
1635
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Higdon L, Cooney L, Serti E, Suwannasaen D, Muir V, Wiedeman A, et al.
J Immunol
. 2025 Mar;
214(1):12-22.
PMID: 40073269
The CD2-depleting drug alefacept (LFA3-Ig) preserved beta cell function in new-onset type 1 diabetes (T1D) patients. The most promising biomarkers of response were late expansion of exhausted CD8 T cells...
2.
Ozcam M, Lin D, Gupta C, Li A, Wheatley L, Baloh C, et al.
medRxiv
. 2024 Jul;
PMID: 39072014
Peanut Oral Immunotherapy (POIT) holds promise for remission of peanut allergy, though treatment is protracted and successful in only a subset of patients. Because the gut microbiome is linked to...
3.
Altman M, Segnitz R, Larson D, Jayavelu N, Smith M, Patel S, et al.
J Allergy Clin Immunol
. 2023 Jul;
152(5):1247-1260.
PMID: 37460024
Background: Allergen immunotherapy (AIT) is a well-established disease-modifying therapy for allergic rhinitis, yet the fundamental mechanisms underlying its clinical effect remain inadequately understood. Gauging Response in Allergic Rhinitis to Sublingual...
4.
Calise J, DeBerg H, Garabatos N, Khosa S, Bajzik V, Calderon L, et al.
J Allergy Clin Immunol
. 2023 Apr;
152(1):155-166.e9.
PMID: 37003475
Background: Despite similar clinical symptoms, peanut-allergic (PA) individuals may respond quite differently to the same therapeutic interventions. Objective: This study aimed to determine whether inherent qualities of cell response at...
5.
Kanchan K, Shankar G, Huffaker M, Bahnson H, Chinthrajah R, Sanda S, et al.
Front Immunol
. 2022 Dec;
13:941839.
PMID: 36466872
Rationale: Previous studies identified an interaction between HLA and oral peanut exposure. HLA-DQA1*01:02 had a protective role with the induction of Ara h 2 epitope-specific IgG4 associated with peanut consumption...
6.
Corren J, Larson D, Altman M, Segnitz R, Avila P, Greenberger P, et al.
J Allergy Clin Immunol
. 2022 Oct;
151(1):192-201.
PMID: 36223848
Background: Thymic stromal lymphopoietin (TSLP) has been shown to play a central role in the initiation and persistence of allergic responses. Objective: We evaluated whether tezepelumab, a human monoclonal anti-TSLP...
7.
Lee J, Fan B, Montenegro G, Long R, Sanda S, Capodanno G, et al.
J Clin Densitom
. 2022 Aug;
25(4):559-568.
PMID: 35941040
No abstract available.
8.
Lambert K, Diggins K, Jones B, Hundhausen C, Maerz M, Hocking A, et al.
Front Immunol
. 2022 Aug;
13:935394.
PMID: 35911690
Elevated levels and enhanced sensing of the pro-inflammatory cytokine interleukin-6 (IL-6) are key features of many autoimmune and inflammatory diseases. To better understand how IL-6 signaling may influence human T...
9.
Jones S, Kim E, Nadeau K, Nowak-Wegrzyn A, Wood R, Sampson H, et al.
Lancet
. 2022 Jan;
399(10322):359-371.
PMID: 35065784
Background: For young children with peanut allergy, dietary avoidance is the current standard of care. We aimed to assess whether peanut oral immunotherapy can induce desensitisation (an increased allergic reaction...
10.
Greenbaum C, Serti E, Lambert K, Weiner L, Kanaparthi S, Lord S, et al.
JCI Insight
. 2021 Nov;
6(21).
PMID: 34747368
BackgroundIL-6 receptor (IL-6R) signaling drives development of T cell populations important to type 1 diabetes pathogenesis. We evaluated whether blockade of IL-6R with monoclonal antibody tocilizumab would slow loss of...